drugset / Trial / NCT04689360

An Intermediate Size Expanded Access Protocol of Elamipretide

NCT04689360

Expanded access Available Stealth BioTherapeutics Inc.

Summary

Choosing to participate in an expanded access program is an important personal decision. Talk with your doctor to learn more about this program. The treating physician must contact StealthBiotherapeutics using the Expanded Access Program Contacts provided. Elamipretide will only be made available after careful review of an individual request submitted by the treating physician. The initiation and conduct of the treatment with elamipretide for an individual patient, and compliance with this treatment guideline, will be under the full and sole responsibility of the treating physician.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Elamipretide Peptide Subcutaneous

Indications